Eli Lilly’s Zepbound pricing shuffle leaves some patients fearing higher costs

Date:

August 28, 2024

When Eli Lilly & Co. on Tuesday announced pricing and packaging changes for its popular weight-loss drug Zepbound, the drugmaker said it was expanding access for people living with obesity — but some patients see the company’s changes as putting the medication further out of reach.

Source link

Auditor faults Pennsylvania agency over fees from Medicaid-funded prescriptions

Think You Can Retire? Seniors Who Have Had to Go Back to Work in Kamala's Economy Say 'Think Again'

Alexandra Williams

Alexandra Williams is a writer and editor. Angeles. She writes about politics, art, and culture for LinkDaddy News.

Eli Lilly’s Zepbound pricing shuffle leaves some patients fearing higher costs

Recent posts

Meta and Amazon donations of $1 million to Trump’s inauguration follow a history of companies cozying up to incoming presidents

Trump’s election win fueled crypto XRP’s rally to a new high. Here’s why its gains may last.

Boeing files NLRB unfair-labor-practice charge against union amid ongoing machinist strike

As the wealthy keep spending, here’s why the middle class is in for a tough 2025

Harris-Trump debate: How the U.S. election may impact bitcoin and other crypto prices

Skechers shares rise on $1 billion buyback, more upbeat outlook

This chart shows gold vs. the stock market since Bernanke’s famous helicopter drop speech

Silver has been outperforming gold this year — and may rise to its own record highs

The Fed is likely to cut interest rates until next summer as the threat of inflation fades

Oil prices slip as geopolitical worries ebb

ASML results could provide insight into AI, China demand

Obesity drugs’ next wave: These companies could snag 20% of GLP-1 market, analysts say

IRS has made ‘limited progress’ figuring out audit rates for those making under $400,000, watchdog says

Five Below’s stock tumbles on CEO departure and downbeat forecast

Oil prices rise as traders await OPEC+ production decision

Related articles

Federal Reserve proposes more transparency in bank stress tests, but banks still sue

Oil prices stuck between geopolitical worries and expectations for surplus

Hyatt may add hotels in Mexico, Jamaica with potential Playa merger

Forget the stock-market tumble — the Fed made the right move in a wild week

Cocoa’s the best-performing commodity in 2024 — and even beat bitcoin. What’s next.

As the wealthy keep spending, here’s why the middle class is in for a tough 2025

How this Treasury-market dynamic could lead to the next big leg lower in stocks

As Teamsters go on strike, Amazon and its investors are trying to shrug it off

Company

Follow us